Mechanisms of action by immunologic adjuvants.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D000941:Antigens / Q000008:administration & dosage*; D001886:Bordetella pertussis / Q000276:immunology; D003078:Colchicine / Q000494:pharmacology; D004926:Escherichia coli / Q000276:immunology; D005620:Freund's Adjuvant / Q000009:adverse effects / Q000494:pharmacology; D007930:Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008081:Liposomes / Q000276:immunology; D008211:Lymphocyte Cooperation; D008264:Macrophages / Q000276:immunology; D051379:Mice; D011063:Poly A-U / Q000494:pharmacology; D011425:Propionibacterium acnes / Q000276:immunology; D012503:Saponins / Q000494:pharmacology
D000276:Adjuvants, Immunologic; D000941:Antigens; D008070:Lipopolysaccharides; D008081:Liposomes; D012503:Saponins; D011063:Poly A-U; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D005620:Freund's Adjuvant; D007930:Leucine; C012211:ubenimex; D003078:Colchicine